Less Ads, More Data, More Tools Register for FREE

hVIVO Raises GBP20.5 Million To Back Portfolio Development (ALLISS)

Thu, 26th Nov 2015 08:59

LONDON (Alliance News) - Life sciences company hVIVO PLC on Thursday said it has conditionally raised GBP20.5 million to back its development portfolio.

The company said it has placed 9.1 million shares with existing institutional shareholders at 225.00 pence per share. Shares in hVIVO were down 7.4% to 235.565p on Thursday morning.

The company said the placing proceeds will be used to progress its PrEP-001 prophylactic compound to phase IIb trials and to advance its asthma and flu treatments.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2015 Alliance News Limited. All Rights Reserved.

Related Shares

More News
3 Jun 2024 12:20

hVIVO says Omicron contract validates move to Canary Wharf facility

(Alliance News) - hVIVO PLC on Monday welcomed a GBP2.5 million contract to start an Omicron characterisation study at its new facility at Canary Whar...

3 Jun 2024 10:35

Hvivo scores £2.5m contract for Omicron characterisation study

(Sharecast News) - Contract research organisation Hvivo has secured a £2.5m contract with a mid-sized pharmaceutical company to initiate an Omicr...

13 May 2024 16:16

UK dividends calendar - next 7 days

11 Apr 2024 15:09

UK dividends calendar - next 7 days

9 Apr 2024 12:03

hVIVO swings to profit and commences annual dividends as outlook rosy

(Alliance News) - hVIVO PLC on Tuesday launched an annual dividend policy, as it swung to profit on the back of higher revenue and a tax credit.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.